Latest Stocks: UnitedHealth Group Inc (UNH) Position Reduced by Moloney Securities Asset Management LLC

Latest Stocks: UnitedHealth Group Inc (UNH) Position Reduced by Moloney Securities Asset Management LLC

Moloney Securities Asset Management LLC cut its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 0.5% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,369 shares of the healthcare conglomerate’s stock after selling 31 shares during the period. Moloney Securities Asset Management LLC’s holdings in UnitedHealth Group were worth $1,044,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Gotham Asset Management LLC increased its stake in UnitedHealth Group by 537.7% in the third quarter. Gotham Asset Management LLC now owns 27,344 shares of the healthcare conglomerate’s stock worth $3,828,000 after buying an additional 23,056 shares during the last quarter. Two Sigma Securities LLC acquired a new stake in UnitedHealth Group during the third quarter worth approximately $1,054,000. Lakeview Capital Partners LLC increased its stake in UnitedHealth Group by 15.2% in the third quarter. Lakeview Capital Partners LLC now owns 4,256 shares of the healthcare conglomerate’s stock worth $596,000 after buying an additional 561 shares during the last quarter. HighTower Advisors LLC increased its stake in UnitedHealth Group by 45.7% in the third quarter. HighTower Advisors LLC now owns 222,232 shares of the healthcare conglomerate’s stock worth $31,152,000 after buying an additional 69,671 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its stake in UnitedHealth Group by 20.4% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 488,630 shares of the healthcare conglomerate’s stock worth $68,408,000 after buying an additional 82,877 shares during the last quarter. Institutional investors own 86.67% of the company’s stock.

UnitedHealth Group Inc (NYSE:UNH) opened at 179.37 on Tuesday. The firm has a 50-day moving average of $173.64 and a 200 day moving average of $165.34. The stock has a market cap of $172.85 billion, a PE ratio of 22.96 and a beta of 0.68. UnitedHealth Group Inc has a 12 month low of $132.39 and a 12 month high of $180.32.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 18th. The healthcare conglomerate reported $2.37 EPS for the quarter, topping the consensus estimate of $2.17 by $0.20. UnitedHealth Group had a net margin of 3.92% and a return on equity of 21.20%. The firm had revenue of $48.72 billion during the quarter, compared to analyst estimates of $48.21 billion. During the same quarter in the prior year, the business posted $1.81 earnings per share. UnitedHealth Group’s revenue for the quarter was up 9.4% compared to the same quarter last year. Analysts anticipate that UnitedHealth Group Inc will post $9.79 EPS for the current year.

A number of research firms have commented on UNH. Vetr downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $186.50 price objective for the company. in a report on Monday. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, May 29th. Jefferies Group LLC reiterated a “buy” rating and issued a $192.00 price objective on shares of UnitedHealth Group in a report on Friday, May 19th. Finally, Deutsche Bank AG reiterated a “buy” rating and issued a $187.00 price objective (up previously from $183.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. Two investment analysts have rated the stock with a hold rating and twenty-two have given a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $183.37.

In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 838 shares of the business’s stock in a transaction that occurred on Wednesday, April 19th. The shares were sold at an average price of $169.12, for a total transaction of $141,722.56. Following the completion of the sale, the director now directly owns 28,528 shares in the company, valued at $4,824,655.36. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Michele J. Hooper sold 15,000 shares of the business’s stock in a transaction that occurred on Thursday, March 16th. The stock was sold at an average price of $170.89, for a total transaction of $2,563,350.00. Following the sale, the director now owns 35,941 shares of the company’s stock, valued at $6,141,957.49. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 34,838 shares of company stock valued at $5,944,983. 1.65% of the stock is owned by insiders. UnitedHealth Group Company Profile

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH). Receive News & Ratings for UnitedHealth Group Inc Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group Inc and related companies with MarketBeat.com’s FREE daily email newsletter.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Related posts

Leave a Comment